Antitumor Potential of the Isoflavonoids (+)- and (−)-2,3,9-Trimethoxypterocarpan: Mechanism-of-Action Studies

Synthetically derived samples of (+)-(6a S ,11a S )-2,3,9-trimethoxypterocarpan [(+)- 1 ] and its enantiomer [(−)- 1 ], both of which are examples of naturally occurring isoflavonoids, were evaluated, together with the corresponding racemate, as cytotoxic agents against the HL-60, HCT-116, OVCAR-8,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS medicinal chemistry letters 2020-06, Vol.11 (6), p.1274-1280
Hauptverfasser: Farias, Kaio, da Costa, Roner F., Meira, Assuero S., Diniz-Filho, Jairo, Bezerra, Eveline M., Freire, Valder N., Guest, Prue, Nikahd, Maryam, Ma, Xinghua, Gardiner, Michael G., Banwell, Martin G., de Oliveira, Maria da C. F., de Moraes, Manoel O., do Ó Pessoa, Claudia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1280
container_issue 6
container_start_page 1274
container_title ACS medicinal chemistry letters
container_volume 11
creator Farias, Kaio
da Costa, Roner F.
Meira, Assuero S.
Diniz-Filho, Jairo
Bezerra, Eveline M.
Freire, Valder N.
Guest, Prue
Nikahd, Maryam
Ma, Xinghua
Gardiner, Michael G.
Banwell, Martin G.
de Oliveira, Maria da C. F.
de Moraes, Manoel O.
do Ó Pessoa, Claudia
description Synthetically derived samples of (+)-(6a S ,11a S )-2,3,9-trimethoxypterocarpan [(+)- 1 ] and its enantiomer [(−)- 1 ], both of which are examples of naturally occurring isoflavonoids, were evaluated, together with the corresponding racemate, as cytotoxic agents against the HL-60, HCT-116, OVCAR-8, and SF-295 tumor cell lines. As a result it was established that compound (+)- 1 was particularly active with OVCAR-8 cells being the most sensitive and responding in a dose-dependent manner. A study of cell viability and drug-induced morphological changes revealed the compound causes cell death through a mechanism characteristic of apoptosis. Finally, a computational study of the interactions of compound (+)- 1 and ( S )-monastrol, an established, synthetically derived, potent, and cell-permeant inhibitor of mitosis, with the kinesin-type protein Eg5 revealed that both bind to this receptor in a similar manner. Significantly, compound (+)- 1 binds with greater affinity, an effect attributed to the presence of the associated methoxy groups.
doi_str_mv 10.1021/acsmedchemlett.0c00097
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7294723</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_7294723</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-3ca41b542b726f64908d32c04e3ed898684a01793df56815be5901d23f7224823</originalsourceid><addsrcrecordid>eNpVkc1Kw0AQgBdRbK2-guyxxW7dnyS760EoxZ9CRcF6DpvNxkSSbMhui30Dzz6iT2JKi9jTzDDMx8x8AFwSPCGYkmulXWVSnZuqNN5PsMYYS34E-kQGAoWCh8f_8h44c-4D40hyjk9Bj9EwJJiQPmimtS_8qrItfLHedIUqoc2gzw2cO5uVam1rW6QODq9GCKo6hcOfr-8RomM2lmjZFpXxuf3cNN60Vqu2UfUNfDI6V3XhKmQzNNW-sDV89au0MO4cnGSqdOZiHwfg7f5uOXtEi-eH-Wy6QJpJ4hHTKiBJGNCE0yiLAolFyqjGgWEmFVJEIlCYcMnSLIwECRMTSkxSyjJOaSAoG4DbHbdZJdtPdae1qoybbmHVbmKriviwUxd5_G7XMacy4JR1gGgH0K11rjXZ3yzB8dZBfOgg3jtgv-7gfwE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Antitumor Potential of the Isoflavonoids (+)- and (−)-2,3,9-Trimethoxypterocarpan: Mechanism-of-Action Studies</title><source>ACS Publications</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Farias, Kaio ; da Costa, Roner F. ; Meira, Assuero S. ; Diniz-Filho, Jairo ; Bezerra, Eveline M. ; Freire, Valder N. ; Guest, Prue ; Nikahd, Maryam ; Ma, Xinghua ; Gardiner, Michael G. ; Banwell, Martin G. ; de Oliveira, Maria da C. F. ; de Moraes, Manoel O. ; do Ó Pessoa, Claudia</creator><creatorcontrib>Farias, Kaio ; da Costa, Roner F. ; Meira, Assuero S. ; Diniz-Filho, Jairo ; Bezerra, Eveline M. ; Freire, Valder N. ; Guest, Prue ; Nikahd, Maryam ; Ma, Xinghua ; Gardiner, Michael G. ; Banwell, Martin G. ; de Oliveira, Maria da C. F. ; de Moraes, Manoel O. ; do Ó Pessoa, Claudia</creatorcontrib><description>Synthetically derived samples of (+)-(6a S ,11a S )-2,3,9-trimethoxypterocarpan [(+)- 1 ] and its enantiomer [(−)- 1 ], both of which are examples of naturally occurring isoflavonoids, were evaluated, together with the corresponding racemate, as cytotoxic agents against the HL-60, HCT-116, OVCAR-8, and SF-295 tumor cell lines. As a result it was established that compound (+)- 1 was particularly active with OVCAR-8 cells being the most sensitive and responding in a dose-dependent manner. A study of cell viability and drug-induced morphological changes revealed the compound causes cell death through a mechanism characteristic of apoptosis. Finally, a computational study of the interactions of compound (+)- 1 and ( S )-monastrol, an established, synthetically derived, potent, and cell-permeant inhibitor of mitosis, with the kinesin-type protein Eg5 revealed that both bind to this receptor in a similar manner. Significantly, compound (+)- 1 binds with greater affinity, an effect attributed to the presence of the associated methoxy groups.</description><identifier>ISSN: 1948-5875</identifier><identifier>EISSN: 1948-5875</identifier><identifier>DOI: 10.1021/acsmedchemlett.0c00097</identifier><identifier>PMID: 32551011</identifier><language>eng</language><publisher>American Chemical Society</publisher><subject>Letter</subject><ispartof>ACS medicinal chemistry letters, 2020-06, Vol.11 (6), p.1274-1280</ispartof><rights>Copyright © 2020 American Chemical Society 2020 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-3ca41b542b726f64908d32c04e3ed898684a01793df56815be5901d23f7224823</citedby><cites>FETCH-LOGICAL-c391t-3ca41b542b726f64908d32c04e3ed898684a01793df56815be5901d23f7224823</cites><orcidid>0000-0002-0582-475X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294723/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294723/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,2752,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Farias, Kaio</creatorcontrib><creatorcontrib>da Costa, Roner F.</creatorcontrib><creatorcontrib>Meira, Assuero S.</creatorcontrib><creatorcontrib>Diniz-Filho, Jairo</creatorcontrib><creatorcontrib>Bezerra, Eveline M.</creatorcontrib><creatorcontrib>Freire, Valder N.</creatorcontrib><creatorcontrib>Guest, Prue</creatorcontrib><creatorcontrib>Nikahd, Maryam</creatorcontrib><creatorcontrib>Ma, Xinghua</creatorcontrib><creatorcontrib>Gardiner, Michael G.</creatorcontrib><creatorcontrib>Banwell, Martin G.</creatorcontrib><creatorcontrib>de Oliveira, Maria da C. F.</creatorcontrib><creatorcontrib>de Moraes, Manoel O.</creatorcontrib><creatorcontrib>do Ó Pessoa, Claudia</creatorcontrib><title>Antitumor Potential of the Isoflavonoids (+)- and (−)-2,3,9-Trimethoxypterocarpan: Mechanism-of-Action Studies</title><title>ACS medicinal chemistry letters</title><description>Synthetically derived samples of (+)-(6a S ,11a S )-2,3,9-trimethoxypterocarpan [(+)- 1 ] and its enantiomer [(−)- 1 ], both of which are examples of naturally occurring isoflavonoids, were evaluated, together with the corresponding racemate, as cytotoxic agents against the HL-60, HCT-116, OVCAR-8, and SF-295 tumor cell lines. As a result it was established that compound (+)- 1 was particularly active with OVCAR-8 cells being the most sensitive and responding in a dose-dependent manner. A study of cell viability and drug-induced morphological changes revealed the compound causes cell death through a mechanism characteristic of apoptosis. Finally, a computational study of the interactions of compound (+)- 1 and ( S )-monastrol, an established, synthetically derived, potent, and cell-permeant inhibitor of mitosis, with the kinesin-type protein Eg5 revealed that both bind to this receptor in a similar manner. Significantly, compound (+)- 1 binds with greater affinity, an effect attributed to the presence of the associated methoxy groups.</description><subject>Letter</subject><issn>1948-5875</issn><issn>1948-5875</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkc1Kw0AQgBdRbK2-guyxxW7dnyS760EoxZ9CRcF6DpvNxkSSbMhui30Dzz6iT2JKi9jTzDDMx8x8AFwSPCGYkmulXWVSnZuqNN5PsMYYS34E-kQGAoWCh8f_8h44c-4D40hyjk9Bj9EwJJiQPmimtS_8qrItfLHedIUqoc2gzw2cO5uVam1rW6QODq9GCKo6hcOfr-8RomM2lmjZFpXxuf3cNN60Vqu2UfUNfDI6V3XhKmQzNNW-sDV89au0MO4cnGSqdOZiHwfg7f5uOXtEi-eH-Wy6QJpJ4hHTKiBJGNCE0yiLAolFyqjGgWEmFVJEIlCYcMnSLIwECRMTSkxSyjJOaSAoG4DbHbdZJdtPdae1qoybbmHVbmKriviwUxd5_G7XMacy4JR1gGgH0K11rjXZ3yzB8dZBfOgg3jtgv-7gfwE</recordid><startdate>20200611</startdate><enddate>20200611</enddate><creator>Farias, Kaio</creator><creator>da Costa, Roner F.</creator><creator>Meira, Assuero S.</creator><creator>Diniz-Filho, Jairo</creator><creator>Bezerra, Eveline M.</creator><creator>Freire, Valder N.</creator><creator>Guest, Prue</creator><creator>Nikahd, Maryam</creator><creator>Ma, Xinghua</creator><creator>Gardiner, Michael G.</creator><creator>Banwell, Martin G.</creator><creator>de Oliveira, Maria da C. F.</creator><creator>de Moraes, Manoel O.</creator><creator>do Ó Pessoa, Claudia</creator><general>American Chemical Society</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0582-475X</orcidid></search><sort><creationdate>20200611</creationdate><title>Antitumor Potential of the Isoflavonoids (+)- and (−)-2,3,9-Trimethoxypterocarpan: Mechanism-of-Action Studies</title><author>Farias, Kaio ; da Costa, Roner F. ; Meira, Assuero S. ; Diniz-Filho, Jairo ; Bezerra, Eveline M. ; Freire, Valder N. ; Guest, Prue ; Nikahd, Maryam ; Ma, Xinghua ; Gardiner, Michael G. ; Banwell, Martin G. ; de Oliveira, Maria da C. F. ; de Moraes, Manoel O. ; do Ó Pessoa, Claudia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-3ca41b542b726f64908d32c04e3ed898684a01793df56815be5901d23f7224823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Letter</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Farias, Kaio</creatorcontrib><creatorcontrib>da Costa, Roner F.</creatorcontrib><creatorcontrib>Meira, Assuero S.</creatorcontrib><creatorcontrib>Diniz-Filho, Jairo</creatorcontrib><creatorcontrib>Bezerra, Eveline M.</creatorcontrib><creatorcontrib>Freire, Valder N.</creatorcontrib><creatorcontrib>Guest, Prue</creatorcontrib><creatorcontrib>Nikahd, Maryam</creatorcontrib><creatorcontrib>Ma, Xinghua</creatorcontrib><creatorcontrib>Gardiner, Michael G.</creatorcontrib><creatorcontrib>Banwell, Martin G.</creatorcontrib><creatorcontrib>de Oliveira, Maria da C. F.</creatorcontrib><creatorcontrib>de Moraes, Manoel O.</creatorcontrib><creatorcontrib>do Ó Pessoa, Claudia</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Farias, Kaio</au><au>da Costa, Roner F.</au><au>Meira, Assuero S.</au><au>Diniz-Filho, Jairo</au><au>Bezerra, Eveline M.</au><au>Freire, Valder N.</au><au>Guest, Prue</au><au>Nikahd, Maryam</au><au>Ma, Xinghua</au><au>Gardiner, Michael G.</au><au>Banwell, Martin G.</au><au>de Oliveira, Maria da C. F.</au><au>de Moraes, Manoel O.</au><au>do Ó Pessoa, Claudia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antitumor Potential of the Isoflavonoids (+)- and (−)-2,3,9-Trimethoxypterocarpan: Mechanism-of-Action Studies</atitle><jtitle>ACS medicinal chemistry letters</jtitle><date>2020-06-11</date><risdate>2020</risdate><volume>11</volume><issue>6</issue><spage>1274</spage><epage>1280</epage><pages>1274-1280</pages><issn>1948-5875</issn><eissn>1948-5875</eissn><abstract>Synthetically derived samples of (+)-(6a S ,11a S )-2,3,9-trimethoxypterocarpan [(+)- 1 ] and its enantiomer [(−)- 1 ], both of which are examples of naturally occurring isoflavonoids, were evaluated, together with the corresponding racemate, as cytotoxic agents against the HL-60, HCT-116, OVCAR-8, and SF-295 tumor cell lines. As a result it was established that compound (+)- 1 was particularly active with OVCAR-8 cells being the most sensitive and responding in a dose-dependent manner. A study of cell viability and drug-induced morphological changes revealed the compound causes cell death through a mechanism characteristic of apoptosis. Finally, a computational study of the interactions of compound (+)- 1 and ( S )-monastrol, an established, synthetically derived, potent, and cell-permeant inhibitor of mitosis, with the kinesin-type protein Eg5 revealed that both bind to this receptor in a similar manner. Significantly, compound (+)- 1 binds with greater affinity, an effect attributed to the presence of the associated methoxy groups.</abstract><pub>American Chemical Society</pub><pmid>32551011</pmid><doi>10.1021/acsmedchemlett.0c00097</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-0582-475X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1948-5875
ispartof ACS medicinal chemistry letters, 2020-06, Vol.11 (6), p.1274-1280
issn 1948-5875
1948-5875
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7294723
source ACS Publications; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Letter
title Antitumor Potential of the Isoflavonoids (+)- and (−)-2,3,9-Trimethoxypterocarpan: Mechanism-of-Action Studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A17%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antitumor%20Potential%20of%20the%20Isoflavonoids%20(+)-%20and%20(%E2%88%92)-2,3,9-Trimethoxypterocarpan:%20Mechanism-of-Action%20Studies&rft.jtitle=ACS%20medicinal%20chemistry%20letters&rft.au=Farias,%20Kaio&rft.date=2020-06-11&rft.volume=11&rft.issue=6&rft.spage=1274&rft.epage=1280&rft.pages=1274-1280&rft.issn=1948-5875&rft.eissn=1948-5875&rft_id=info:doi/10.1021/acsmedchemlett.0c00097&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_7294723%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32551011&rfr_iscdi=true